NANOBIOTIX EUR0.03NANOBIOTIX EUR0.03NANOBIOTIX EUR0.03

NANOBIOTIX EUR0.03

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪150.87 M‬EUR
−0.738EUR
‪−39.70 M‬EUR
‪30.06 M‬EUR
‪45.83 M‬
Beta (1Y)
1.20
Employees (FY)
102
Change (1Y)
0
Revenue / Employee (1Y)
‪294.69 K‬EUR
Net income / Employee (1Y)
‪−389.22 K‬EUR

About NANOBIOTIX


CEO
Laurent Lévy
Headquarters
Paris
Founded
2003
ISIN
FR0011341205
FIGI
BBG00SYG78H2
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0QAV is 3.196 EUR — it has decreased by −3.44% in the past 24 hours. Watch NANOBIOTIX EUR0.03 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NANOBIOTIX EUR0.03 stocks are traded under the ticker 0QAV.
0QAV stock has fallen by −6.77% compared to the previous week, the month change is a −12.96% fall, over the last year NANOBIOTIX EUR0.03 has showed a −42.62% decrease.
We've gathered analysts' opinions on NANOBIOTIX EUR0.03 future price: according to them, 0QAV price has a max estimate of 16.00 EUR and a min estimate of 9.50 EUR. Watch 0QAV chart and read a more detailed NANOBIOTIX EUR0.03 stock forecast: see what analysts think of NANOBIOTIX EUR0.03 and suggest that you do with its stocks.
0QAV reached its all-time high on Jan 18, 2021 with the price of 17.060 EUR, and its all-time low was 1.624 EUR and was reached on May 4, 2023. View more price dynamics on 0QAV chart.
See other stocks reaching their highest and lowest prices.
0QAV stock is 5.08% volatile and has beta coefficient of 1.20. Track NANOBIOTIX EUR0.03 stock price on the chart and check out the list of the most volatile stocks — is NANOBIOTIX EUR0.03 there?
Today NANOBIOTIX EUR0.03 has the market capitalization of ‪150.85 M‬, it has increased by 3.77% over the last week.
Yes, you can track NANOBIOTIX EUR0.03 financials in yearly and quarterly reports right on TradingView.
NANOBIOTIX EUR0.03 is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
0QAV earnings for the last half-year are −0.46 EUR per share, whereas the estimation was −0.46 EUR, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.63 EUR per share. See more details about NANOBIOTIX EUR0.03 earnings.
NANOBIOTIX EUR0.03 revenue for the last half-year amounts to ‪9.30 M‬ EUR, despite the estimated figure of ‪9.30 M‬ EUR. In the next half-year revenue is expected to reach ‪6.00 M‬ EUR.
0QAV net income for the last half-year is ‪−21.87 M‬ EUR, while the previous report showed ‪−11.60 M‬ EUR of net income which accounts for −88.54% change. Track more NANOBIOTIX EUR0.03 financial stats to get the full picture.
No, 0QAV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 102.00 employees. See our rating of the largest employees — is NANOBIOTIX EUR0.03 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NANOBIOTIX EUR0.03 EBITDA is ‪−26.81 M‬ EUR, and current EBITDA margin is −96.04%. See more stats in NANOBIOTIX EUR0.03 financial statements.
Like other stocks, 0QAV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANOBIOTIX EUR0.03 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANOBIOTIX EUR0.03 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANOBIOTIX EUR0.03 stock shows the sell signal. See more of NANOBIOTIX EUR0.03 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.